Resultats de la cerca - Javier Bolaños‐Meade
- Mostrar 1 - 20 resultats de 58
- Anar a la pàgina següent
-
1
-
2
HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease per Javier Bolaños‐Meade, Ephraim J. Fuchs, Leo Luznik, Sophie Lanzkron, Christopher Gamper, Richard J. Jones, Robert A. Brodsky
Publicat 2012Artigo -
3
-
4
-
5
Acute graft-versus-host disease biomarkers measured during therapy can predict treatment outcomes: a Blood and Marrow Transplant Clinical Trials Network study per John E. Levine, Brent R. Logan, Juan Wu, Amin M. Alousi, Javier Bolaños‐Meade, James L.M. Ferrara, Vincent T. Ho, Daniel J. Weisdorf, Sophie Paczesny
Publicat 2012Artigo -
6
Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide per Christopher G. Kanakry, Sudipto Ganguly, Marianna Zahurak, Javier Bolaños‐Meade, Christopher J. Thoburn, Brandy Perkins, Ephraim J. Fuchs, Richard J. Jones, Allan D. Hess, Leo Luznik
Publicat 2013Artigo -
7
Pentostatin in Steroid-Refractory Acute Graft-Versus-Host Disease per Javier Bolaños‐Meade, David A. Jacobsohn, Jeffrey Margolis, Adam Ogden, M. Guillaume Wientjes, John C. Byrd, David Lucas, Viki Anders, Michele Phelps, Michael R. Grever, Georgia B. Vogelsang
Publicat 2005Artigo -
8
A prognostic score for acute graft-versus-host disease based on biomarkers: a multicentre study per John E. Levine, Thomas M. Braun, Andrew C. Harris, Ernst Holler, Austin Taylor, Holly Miller, John Magenau, Daniel J. Weisdorf, Vincent T. Ho, Javier Bolaños‐Meade, Amin M. Alousi, James L.M. Ferrara
Publicat 2014Artigo -
9
HLA-Haploidentical Donor Lymphocyte Infusions for Patients with Relapsed Hematologic Malignancies after Related HLA-Haploidentical Bone Marrow Transplantation per Amer M. Zeidan, Patrick M. Forde, Heather J. Symons, Allen Chen, Benjamin D. Smith, Keith W. Pratz, Hetty E. Carraway, Douglas E. Gladstone, Ephraim J. Fuchs, Leo Luznik, Richard J. Jones, Javier Bolaños‐Meade
Publicat 2013Artigo -
10
Phase II Study of Risk-Adapted Therapy of Newly Diagnosed, Aggressive Non-Hodgkin Lymphoma Based on Midtreatment FDG-PET Scanning per Yvette L. Kasamon, Richard L. Wahl, Harvey A. Ziessman, Amanda L. Blackford, Steven N. Goodman, Caroline A. Fidyk, Kathryn Rogers, Javier Bolaños‐Meade, Michael J. Borowitz, Richard F. Ambinder, Richard J. Jones, Lode J. Swinnen
Publicat 2009Artigo -
11
Etanercept, mycophenolate, denileukin, or pentostatin plus corticosteroids for acute graft-versus-host disease: a randomized phase 2 trial from the Blood and Marrow Transplant Clin... per Amin M. Alousi, Daniel J. Weisdorf, Brent R. Logan, Javier Bolaños‐Meade, Shelly Carter, Nancy DiFronzo, Marcelo C. Pasquini, Steven C. Goldstein, Vincent T. Ho, Brandon Hayes‐Lattin, John R. Wingard, Mary M. Horowitz, John E. Levine
Publicat 2009Artigo -
12
American Society of Hematology 2021 guidelines for sickle cell disease: stem cell transplantation per Julie Kanter, Robert I. Liem, Françoise Bernaudin, Javier Bolaños‐Meade, Courtney D. Fitzhugh, Jane S. Hankins, M. Hassan Murad, Julie A. Panepinto, Damiano Rondelli, Shalini Shenoy, John E. Wagner, Mark C. Walters, Teonna Woolford, Joerg J Meerpohl, John F. Tisdale
Publicat 2021Artigo -
13
Outcomes of Related Donor HLA-Identical or HLA-Haploidentical Allogeneic Blood or Marrow Transplantation for Peripheral T Cell Lymphoma per Jennifer A. Kanakry, Yvette L. Kasamon, Christopher D. Gocke, Hua-Ling Tsai, Janice Davis‐Sproul, Nilanjan Ghosh, Heather J. Symons, Javier Bolaños‐Meade, Douglas E. Gladstone, Lode J. Swinnen, Leo Luznik, Ephraim J. Fuchs, Richard J. Jones, Richard F. Ambinder
Publicat 2013Artigo -
14
Prospective study of nonmyeloablative, HLA-mismatched unrelated BMT with high-dose posttransplantation cyclophosphamide per Yvette L. Kasamon, Richard F. Ambinder, Ephraim J. Fuchs, Marianna Zahurak, Gary L. Rosner, Javier Bolaños‐Meade, Mark J. Levis, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, William Matsui, Ivan Borrello, Robert A. Brodsky, Richard J. Jones, Leo Luznik
Publicat 2017Artigo -
15
Clinical activity of sequential flavopiridol, cytosine arabinoside, and mitoxantrone for adults with newly diagnosed, poor-risk acute myelogenous leukemia per Judith E. Karp, Amanda L. Blackford, B. Douglas Smith, Katrina Alino, Amy Hatfield Seung, Javier Bolaños‐Meade, Jacqueline M. Greer, Hetty E. Carraway, Steven D. Gore, Richard J. Jones, Mark J. Levis, Michael A. McDevitt, L. Austin Doyle, James R. Wright
Publicat 2009Artigo -
16
Grade II Acute Graft-versus-Host Disease and Higher Nucleated Cell Graft Dose Improve Progression-Free Survival after HLA-Haploidentical Transplant with Post-Transplant Cyclophosph... per Shannon R. McCurdy, Christopher G. Kanakry, Hua-Ling Tsai, Yvette L. Kasamon, Margaret M. Showel, Javier Bolaños‐Meade, Carol Ann Huff, Ivan Borrello, William Matsui, Robert A. Brodsky, Richard F. Ambinder, Maria Bettinotti, Ephraim J. Fuchs, Gary L. Rosner, Richard J. Jones, Leo Luznik
Publicat 2017Artigo -
17
Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study per Mary Eapen, Ruta Brazauskas, Mark C. Walters, Françoise Bernaudin, Khalid Bo-Subait, Courtney D. Fitzhugh, Jane S. Hankins, Julie Kanter, Joerg J Meerpohl, Javier Bolaños‐Meade, Julie A. Panepinto, Damiano Rondelli, Shalini Shenoy, Joi Williamson, Teonna Woolford, Éliane Gluckman, John E. Wagner, John F. Tisdale
Publicat 2019Artigo -
18
Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation per John R. Wingard, Shelly L. Carter, Thomas J. Walsh, Joanne Kurtzberg, Trudy N. Small, Lindsey R. Baden, Iris D. Gersten, Adam Mendizabal, Helen Leather, Dennis L. Confer, Richard T. Maziarz, Edward A. Stadtmauer, Javier Bolaños‐Meade, J. Martin Brown, John F. DiPersio, Michael Boeckh, Kieren A. Marr
Publicat 2010Artigo -
19
High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease per Leo Luznik, Javier Bolaños‐Meade, Marianna Zahurak, Allen Chen, B. Douglas Smith, Robert A. Brodsky, Carol Ann Huff, Ivan Borrello, William Matsui, Jonathan D. Powell, Yvette L. Kasamon, Steven N. Goodman, Allan D. Hess, Hyam I. Levitsky, Richard F. Ambinder, Richard J. Jones, Ephraim J. Fuchs
Publicat 2010Artigo -
20
Shortened-Duration Tacrolimus after Nonmyeloablative, HLA-Haploidentical Bone Marrow Transplantation per Yvette L. Kasamon, Ephraim J. Fuchs, Marianna Zahurak, Gary L. Rosner, Heather J. Symons, Douglas E. Gladstone, Carol Ann Huff, Lode J. Swinnen, Robert A. Brodsky, William Matsui, Ivan Borrello, Satish Shanbhag, Kenneth R. Cooke, Richard F. Ambinder, Leo Luznik, Javier Bolaños‐Meade, Richard J. Jones
Publicat 2018Artigo
Eines de cerca:
Matèries relacionades
Medicine
Internal medicine
Transplantation
Chemotherapy
Cyclophosphamide
Surgery
Graft-versus-host disease
Gastroenterology
Immunology
Oncology
Biology
Bone marrow
Hematopoietic stem cell transplantation
Physics
Antigen
Disease
Human leukocyte antigen
Cumulative incidence
Incidence (geometry)
Optics
Clinical trial
Confidence interval
Randomized controlled trial
Stem cell
Calcineurin
Genetics
Haematopoiesis
Clinical endpoint
Hematopoietic cell
Lymphoma